345 related articles for article (PubMed ID: 33386542)
21. Laparoscopic versus open pancreatic resection for ductal adenocarcinoma: separate propensity score matching analyses of distal pancreatectomy and pancreaticoduodenectomy.
Chen K; Pan Y; Huang CJ; Chen QL; Zhang RC; Zhang MZ; Wang GY; Wang XF; Mou YP; Yan JF
BMC Cancer; 2021 Apr; 21(1):382. PubMed ID: 33836678
[TBL] [Abstract][Full Text] [Related]
22. Neoadjuvant Therapy for Pancreatic Cancer: Increased Use and Improved Optimal Outcomes.
Davis CH; Beane JD; Gazivoda VP; Grandhi MS; Greenbaum AA; Kennedy TJ; Langan RC; August DA; Alexander HR; Pitt HA
J Am Coll Surg; 2022 Apr; 234(4):436-443. PubMed ID: 35290262
[TBL] [Abstract][Full Text] [Related]
23. Preoperative serum CA19-9 predicts postoperative pancreatic fistula in PDAC patients: retrospective analysis at a single institution.
Sugita H; Okabe H; Ogawa D; Hirao H; Kuroda D; Taki K; Tomiyasu S; Hirota M
BMC Surg; 2022 Oct; 22(1):367. PubMed ID: 36307795
[TBL] [Abstract][Full Text] [Related]
24. Diabetes mellitus does not impact on clinically relevant pancreatic fistula after partial pancreatic resection for ductal adenocarcinoma.
Malleo G; Mazzarella F; Malpaga A; Marchegiani G; Salvia R; Bassi C; Butturini G
Surgery; 2013 May; 153(5):641-50. PubMed ID: 23276391
[TBL] [Abstract][Full Text] [Related]
25. Neoadjuvant therapy for pancreatic cancer changes the composition of the pancreatic parenchyma.
Rykina-Tameeva N; Nahm CB; Mehta S; Gill AJ; Samra JS; Mittal A
HPB (Oxford); 2020 Nov; 22(11):1631-1636. PubMed ID: 32247587
[TBL] [Abstract][Full Text] [Related]
26. Survival benefit of neoadjuvant therapy in patients with non-metastatic pancreatic ductal adenocarcinoma: A propensity matching and intention-to-treat analysis.
Sugimoto M; Takahashi N; Farnell MB; Smyrk TC; Truty MJ; Nagorney DM; Smoot RL; Chari ST; Carter RE; Kendrick ML
J Surg Oncol; 2019 Nov; 120(6):976-984. PubMed ID: 31452208
[TBL] [Abstract][Full Text] [Related]
27. Surgical approach to pancreaticoduodenectomy for pancreatic adenocarcinoma: uncomplicated ends justify the means.
Naffouje SA; Pointer DT; Satyadi MA; Hodul P; Anaya DA; Pimiento J; Malafa M; Kim DW; Fleming JB; Denbo JW
Surg Endosc; 2022 Jul; 36(7):4912-4922. PubMed ID: 34859301
[TBL] [Abstract][Full Text] [Related]
28. Impact of Neoadjuvant Treatment and Minimally Invasive Surgery on Perioperative Outcomes of Pancreatoduodenectomy: an ACS NSQIP Analysis.
Al Abbas AI; Meier J; Hester CA; Radi I; Yan J; Zhu H; Mansour JC; Porembka MR; Wang SC; Yopp AC; Zeh HJ; Polanco PM
J Gastrointest Surg; 2023 Dec; 27(12):2823-2842. PubMed ID: 37903972
[TBL] [Abstract][Full Text] [Related]
29. The Oncologic Impact of Pancreatic Fistula After Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma of the Body and the Tail: A Multicenter Retrospective Cohort Analysis.
Leon P; Giannone F; Belfiori G; Falconi M; Crippa S; Boggi U; Menonna F; Al Sadairi AR; Piardi T; Sulpice L; Gardini A; Sega V; Chirica M; Ravazzoni F; Giannandrea G; Pessaux P; de Blasi V; Navarro F; Panaro F
Ann Surg Oncol; 2021 Jun; 28(6):3171-3183. PubMed ID: 33156465
[TBL] [Abstract][Full Text] [Related]
30. A Propensity Score-Matched Analysis of Robotic vs Open Pancreatoduodenectomy on Incidence of Pancreatic Fistula.
McMillan MT; Zureikat AH; Hogg ME; Kowalsky SJ; Zeh HJ; Sprys MH; Vollmer CM
JAMA Surg; 2017 Apr; 152(4):327-335. PubMed ID: 28030724
[TBL] [Abstract][Full Text] [Related]
31. Thirty-day complication rates do not differ by race among patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma.
Mitsakos AT; Dennis SO; Parikh AA; Snyder RA
J Surg Oncol; 2021 Mar; 123(4):970-977. PubMed ID: 33497474
[TBL] [Abstract][Full Text] [Related]
32. Neck transection level and postoperative pancreatic fistula after pancreaticoduodenectomy: A retrospective cohort study of 195 patients.
Bardol T; Delicque J; Hermida M; Herrero A; Guiu B; Fabre JM; Souche R
Int J Surg; 2020 Oct; 82():43-50. PubMed ID: 32841726
[TBL] [Abstract][Full Text] [Related]
33. Neoadjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma is Associated with Lower Post-Pancreatectomy Readmission Rates: A Population-Based Cohort Study.
Kamarajah SK; Naffouje SA; Salti GI; Dahdaleh FS
Ann Surg Oncol; 2021 Apr; 28(4):1896-1905. PubMed ID: 33398644
[TBL] [Abstract][Full Text] [Related]
34. Should Drains Suck? A Propensity Score Analysis of Closed-Suction Versus Closed-Gravity Drainage After Pancreatectomy.
Kone LB; Maker VK; Banulescu M; Maker AV
J Gastrointest Surg; 2021 May; 25(5):1224-1232. PubMed ID: 32394123
[TBL] [Abstract][Full Text] [Related]
35. Short- and mid-term outcomes of robotic versus laparoscopic distal pancreatosplenectomy for pancreatic ductal adenocarcinoma: A retrospective propensity score-matched study.
Qu L; Zhiming Z; Xianglong T; Yuanxing G; Yong X; Rong L; Yee LW
Int J Surg; 2018 Jul; 55():81-86. PubMed ID: 29802919
[TBL] [Abstract][Full Text] [Related]
36. The pancreatic juice length in the stent tube as the predicting factor of clinical relevant postoperative pancreatic fistula after pancreaticoduodenectomy.
Wang H; Xiu D; Tao M
Medicine (Baltimore); 2017 Nov; 96(44):e8451. PubMed ID: 29095290
[TBL] [Abstract][Full Text] [Related]
37. Pancreatic Fistula and Delayed Gastric Emptying Are the Highest-Impact Complications After Whipple.
Mirrielees JA; Weber SM; Abbott DE; Greenberg CC; Minter RM; Scarborough JE
J Surg Res; 2020 Jun; 250():80-87. PubMed ID: 32023494
[TBL] [Abstract][Full Text] [Related]
38. Nationwide trends and outcomes of neoadjuvant chemotherapy in pancreatic cancer - an analysis of the Swedish national pancreatic cancer registry.
Sternby H; Andersson B
Scand J Gastroenterol; 2022 Nov; 57(11):1361-1366. PubMed ID: 35635264
[TBL] [Abstract][Full Text] [Related]
39. Laparoscopic distal pancreatectomy for pancreatic cancer is safe and effective.
Bauman MD; Becerra DG; Kilbane EM; Zyromski NJ; Schmidt CM; Pitt HA; Nakeeb A; House MG; Ceppa EP
Surg Endosc; 2018 Jan; 32(1):53-61. PubMed ID: 28643065
[TBL] [Abstract][Full Text] [Related]
40. Pancreatic adenocarcinoma: effects of neoadjuvant therapy on post-pancreatectomy outcomes - an American College of Surgeons National Surgical Quality Improvement Program targeted variable review.
Czosnyka NM; Borgert AJ; Smith TJ
HPB (Oxford); 2017 Oct; 19(10):927-932. PubMed ID: 28747265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
